Experiments on human glioma U251 cells showed that EPHA4 promoted fibroblast growth factor 2 (FGF2)-mediated cell proliferation and migration, along with increased MAPK and Akt phosphorylation stimulated by FGF2. This evidence concerns the gene FGF2 and central nervous system cancer.